European Healthcare Acquisitions & Growth and Croma-Pharma GmbH along with Croma’s shareholders decided to terminate their business combination agreement and their discussions due to differing views on the currently realizable value of Croma.
EHC is now exploring alternative options and will update its shareholders on such plans in the near future, EQS News reports. Read more.
